No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Constant Use of Heartburn and Acid Reflux Drugs Like Zantac Could Double Cancer Risks

Thursday, February 4th is World Cancer Day and medical publications focus on how taking Zantac could cause the disease

Friday, February 5, 2021 - With Zantac, the world's leading heartburn medicine no longer available, heartburn sufferers should be aware of how serious a condition they have. Extreme episodes of heartburn may also be confused with the onset of a life-threatening heart attack. Heartburn pain could also be nothing more than little indigestion from overeating. When we overeat stomach contents prevent the esophageal sphincter from completely closing and some stomach acid can seep out. For women, pregnancy can also be accompanied by episodes of extreme heartburn pain. Zantac cancer lawyers offer a no obligation, free consultation if you or a loved one suffered from stomach cancer due to taking Zantac.

Thursday, February 4th is World Cancer Day and major medical publications around the world are focused on this disease. Some have chosen to tell remind readers that in 2020, it was discovered that taking ranitidine and other antacids for relief of heartburn and acid reflux pain may cause cancer of the stomach, bladder, and other areas of the digestive system. Doctor's writing for the Economic Times of India (ETI) has identified ways in which common heartburn medicines like Zantac may be linked with increases in stomach cancer. Certain spicy or oily foods are more difficult for the digestive system to break down and can trigger an increase in stomach acid. This increase in stomach acid can lead to painful irritation of the stomach lining and ulcers may develop. If this occurs repeatedly, the ulcers may progress to cancerous tumors. Early symptoms to watch for that could signal a stomach tumor include "difficulty in swallowing, blood in vomit and voice change," According to ETI.

The India Times is warning readers to seek answers for their heartburn and acid reflux pain from making positive diet and lifestyle changes and not to take the easy road by popping a pill. The IT warns readers, "Recent studies have shown that one of the groups of antacid pills (Ranitidine group) produce some cancer-inducing substances and banned in the US. The drug was recalled in the US market. Another group of drugs called the Proton Pump Inhibitors double the risk of developing gastric cancer over long-term use in Hong Kong." While the Zantac news is nothing new, linking gastric cancer with PPI drugs could be shocking to some. The US Food and Drug Administration (FDA) has advised people to switch to PPI drugs after banning ranitidine and Zantac. Doctors tell IT, "It is essential to adopt a healthy lifestyle with a balanced diet which includes avoiding oily meals and caffeine, limiting alcohol, and quitting smoking. One should also ensure small intervals between eating and lying down."

People with stomach and other forms of cancer of the digestive system have filed suit against Sanofi, the maker of Zantac, for failing to warn them of what they knew or should have known about Zantac and cancer. If you have taken Zantac regularly, you should see your doctor for preemptive cancer screening.

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.